Corrigendum: Abd El Bary et al. Cost Effectiveness Analysis of Letrozole Compared with Tamoxifen as Initial Adjuvant Therapy for Postmenopausal Women with Endocrine Responsive Bre - Egyptian Knowledge Bank

18648

Corrigendum: Abd El Bary et al. Cost Effectiveness Analysis of Letrozole Compared with Tamoxifen as Initial Adjuvant Therapy for Postmenopausal Women with Endocrine Responsive Bre

Article

Last updated: 01 Jan 2025

Overview Similar Items

Article

Corrigendum: El-beshbeshi et al. Prognostic Significance of Lymph Node Ratio after Cervical Lymph Node Dissection in Head and Neck Squamous Cell Carcinoma. <i>Res Oncol</i>. 2020;

Article

Letrozole and Anastrozole in Early Breast Cancer Post-menopausal Patients in Oncology Department at Suez Canal University Hospital

Article

A Retrospective Study on Screening and Management of Osteoporosis in Breast Cancer Women Treated With Aromatase Inhibitors in Libya

Article

Tamoxifen versus Tamoxifen and Ovarian Suppression in Premenopausal Hormone Positive early Breast Cancer (Retrospective study)

Article

Letrozole plus Simvastatin versus Letrozole in Denovo Metastatic HER2/neu Negative Luminal Breast Cancer: A phase II Randomized Controlled Trial

Article

Erratum

Article

IMPACT OF LETROZOLE TREATMENT ON LIPID PROFILE IN POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR-POSITIVE EARLY BREAST CANCER: A PROSPECTIVE STUDY

Article

Cost-Effectiveness of National Breast Cancer Screening Programs in Developing Countries, with Reference to the Recent Egyptian Initiative

Article

Adherence and Discontinuation of Endocrine Therapy among Egyptian Breast Cancer Patients Receiving Adjuvant Treatment: A Cross-sectional Study

Article

Factors affecting Adherence to Adjuvant Hormonal Therapy among Women with Breast Cancer